[144] Dolby Laboratories, Inc. SEC Filing
Rhea-AI Filing Summary
Dolby Laboratories (DLB) has a Form 144 notice indicating a planned sale of 36,699 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of
The shares to be sold were acquired on 11/24/2025 via a stock option exercise from the issuer, paid in cash, on the same date. Over the past three months, the Yeaman Family Trust sold 25,000 common shares on 10/14/2025 for gross proceeds of
Positive
- None.
Negative
- None.
FAQ
What does the Dolby (DLB) Form 144 filing disclose?
The Form 144 shows a planned sale of 36,699 Dolby common shares on the NYSE under Rule 144, with an aggregate market value of
How many Dolby (DLB) shares are planned to be sold and through which broker?
The notice covers 36,699 common shares of Dolby to be sold through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.
When are the Dolby (DLB) shares expected to be sold under this Form 144?
The approximate date of sale listed is 11/24/2025, with the shares to be sold on the NYSE.
How were the Dolby (DLB) shares in this Form 144 acquired?
The 36,699 common shares were acquired from the issuer on 11/24/2025 via a stock option exercise, paid in cash on that same date.
How many Dolby (DLB) shares are outstanding according to this notice?
The filing states that there are 60,845,846 Dolby common shares outstanding.
What Dolby (DLB) share sales occurred in the past 3 months for this seller?
The Yeaman Family Trust sold 25,000 common shares on 10/14/2025 for
What representation does the seller make about Dolby (DLB) in the Form 144?
The seller represents that they do not know of any material adverse information about Dolby’s current or prospective operations that has not been publicly disclosed.